Tag: Pluristem
Allogeneic stem cell therapy for peripheral artery disease raises hopes globally
Encouraging Phase II results were released in June 2018 for PLX-PAD, a placenta-based allogeneic stem cell therapy given intramuscularly, targeting peripheral artery disease (PAD)........................